Nora Denzel - 13 Sep 2022 Form 4 Insider Report for NortonLifeLock Inc. (GEN)

Role
Director
Signature
/s/ Bryan Ko, as attorney-in-fact for Nora Denzel
Issuer symbol
GEN
Transactions as of
13 Sep 2022
Transactions value $
$0
Form type
4
Filing time
15 Sep 2022, 17:28:45 UTC
Previous filing
20 May 2022
Next filing
22 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEN Common Stock Award $0 +12K +45.78% $0.00 38.1K 13 Sep 2022 Direct F1
transaction GEN Common Stock Award $0 +5.01K +13.14% $0.00 43.1K 13 Sep 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the reporting person's service as a non-employee director of the Issuer for the period between September 13, 2022 and September 12, 2023, pursuant to the non-employee director grant policy, such reporting person has been granted restricted stock units. 100% of the restricted stock units will vest on the first year anniversary of the grant date.
F2 Director retainer fee issued in stock for the period between September 13, 2022 and September 12, 2023. The restricted stock units will vest quarterly during the one year period following the grant date